For spatial, single-cell, liquid biopsy and AI discovery vendors: meet California translational teams early in the 2027 budget year, in a Stream 2 program built around their work.
Sponsor San Diego 2027
Our sponsorship team replies within one working day.
Trusted by sponsors from our London 2026 launch edition

ImmunoMark is an oncology biomarker conference in San Diego for the teams that find and test biomarkers before anyone writes a companion diagnostic plan. If you sell spatial biology, single-cell, liquid biopsy or AI discovery tools, those teams are your buyers, and the Stream 2 program on 10–11 February 2027 is built around their work.
Discovery-stage tools have a specific sales problem. The scientist who runs the pilot is rarely the person who signs off on a platform decision, and the person who signs off rarely shows up at a methods meeting. ImmunoMark puts both in the same room: the audience profile is 20–30% scientists, PIs and technologists and 45–50% senior leadership, with 55–60% from biotech and pharma.
That mix matters for a cancer biomarker conference in San Diego. You can run a technical conversation with a principal scientist in the morning and a budget conversation with their head of translational medicine at the Day 1 drinks reception.
Day 1 of Stream 2 reads like a discovery-tools roadmap. These are real sessions from the San Diego agenda.
The sponsor talk slots sit inside this sequence. Stream 2 Platinum slots run on Day 1 at 11:00, 12:30 and 14:30, so a Platinum talk lands either side of the liquid biopsy and spatial sessions. Gold slots run on Day 2 before lunch, starting at 10:00, straight after the single-cell session. For a cross-edition view of how these technologies show up in San Diego and London, see the biomarker technology sponsor page, and for background on choosing between spatial methods, our article on spatial proteomics vs spatial transcriptomics.
San Diego sits within reach of the state’s other biotech clusters, and the speaker faculty reflects that.
The San Diego agenda lists speakers from companies with California R&D bases, including Genentech, Gilead Sciences, Amgen, Xencor, Janux Therapeutics, Nkarta and ArsenalBio. Their titles tell you who is in the discovery and translational conversation: Director, Pathobiology at Gilead Sciences; Senior Director, Translational Biology at Xencor; Head of Translational Medicine at Janux Therapeutics; Senior Principal Scientist at Genentech.
Pathobiology and translational biology leads who need tissue context for immunotherapy response, and who will sit in the spatial session and the digital pathology panel.
Translational scientists characterizing immune cells and resistance, the core audience for the Day 2 single-cell session.
Teams building longitudinal monitoring and multi-omic models, drawn by the MRD session and the J&J NSCLC resistance talk.
One sponsorship covers buyers from San Diego, the Bay Area and Los Angeles without three separate regional events. If your company is based in San Diego itself, the home-turf sponsor page covers how local teams get more from the same package.
A February date puts your sponsorship near the start of most 2027 budget years, before pipeline targets for the year are set in stone. If you are shortlisting biomarker conferences for 2027 in the USA, that timing is the reason to decide early.
See what a February sponsorship returns against your 2027 targets.
Run the ROI calculatorDiscovery tools sell on data and conversations, so the best packages combine a talk in the right session block with enough 1:1 meetings to follow it up.
Puts your talk on Day 1, in the block where the multi-omics, liquid biopsy and spatial sessions run, with the meeting volume to convert it.
A strong fit for single-cell and functional assay vendors: Day 2 pre-lunch slots follow the single-cell session.
For early-stage tool companies that want pilot conversations without a booth or talk.
Every tier includes the delegate list with contact details and post-event branding. Full details are on the San Diego sponsorship opportunities page. If you also sell into the UK, the London oncology biomarker page covers the same discovery-tools angle for March.
Stream 2 Platinum and Gold slots are limited. Ask which are still open.
Request the prospectusPick a package, add your own numbers and see the pipeline it creates. London 2026 sponsors averaged 15 to 25 meetings each, with 70% senior decision-makers in the room.
1. Choose a package
2. Your numbers
Year-one value of a new pharma or biotech customer
Booth visits, networking and questions after your talk
Share of conversations worth a proposal
Your typical close rate
Sponsorship plus travel and team costs
expected first-year revenue for every $1 of your event budget
Estimates only, based on the numbers you enter. Meetings and inclusions from the San Diego 2027 sponsorship prospectus. 1:1 meetings are pre-scheduled with delegates you choose from the attendee list.
What sponsors said
Here is what sponsors told us at our London 2026 launch edition.
We really liked the focus of the event, the topics, the talks, really good opportunity to engage with people, the support we get from you is really great and we appreciate that very much. Based on our experience we would be very interested in also sponsoring the next annual event.

We are always interested in sponsoring interesting conference, based on this years experience, I guess I will manage to get some budget for the next edition.

Conversations I have had are very high level, the footfalls been great and the kind of research going on around is really life changing. We will be very interested in sponsoring the second annual.

My experience here at Immunomark 2026 has been really great. We benefit from very good logistical organisation. Networking sessions were excellent and we consider Immunomark a strategic conference for the coming years.

We got the occasion to discuss customer projects and understand their needs better and how we can help them.

The conference has been great so far with strong interactions at the booth and excellent attendance at our talk. We will definitely think about the next edition.

Quality of the talks were really nice and the attendee list had experts from biotech pharma field. It was great meeting everyone and we look forward to positive outcomes.

The talks have been really interesting so far with a great combination of researchers and clinicians. Moderators encouraged excellent discussions.

No. Stream 2 in San Diego opens with discovery and translational content: multi-omics for predictive biomarkers, multi-omic and AI approaches to immunotherapy resistance in NSCLC, liquid biopsy and MRD, spatial omics, AI-driven digital pathology and single-cell technologies. CDx and commercial sessions come later in the program, so you meet the same teams at both ends.
Platinum. Stream 2 Platinum slots are on Day 1 at 11:00, 12:30 and 14:30. The liquid biopsy and MRD session runs at 11:30 and the spatial omics session at 12:00, so a Platinum talk sits directly before or after them.
The speaker faculty includes companies with California R&D bases such as Genentech, Gilead Sciences, Amgen, Xencor, Nkarta and ArsenalBio. You choose your 1:1 meetings from the full delegate list and profiles, so you can target the organizations that matter to you wherever they are based.
Ten days before the event you receive the full delegate list with profiles and choose who you want to meet. Each meeting is 20 minutes and pre-scheduled. The wishlist feature helps you flag priority contacts.
For most vendors it falls early in the budget year, which is why committing in the fourth quarter of 2026 helps: you secure your stream and talk slot, and your logo is on the event website while the delegate list is still building.
Tell us who you want to meet. We will send the prospectus, current package availability and a recommendation within one working day.